Live Music in the Intensive Care Unit
Launched by AARHUS UNIVERSITY HOSPITAL · Jun 3, 2024
Trial Information
Current as of June 30, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether listening to live music can help reduce stress and pain in adults who are critically ill and in the intensive care unit (ICU). The researchers want to find out if this type of music intervention makes a difference in important health measurements, such as heart rate, breathing rate, and blood pressure. Participants will listen to live music for about 5 to 15 minutes in their ICU rooms, and the researchers will compare their health measurements before and after the music to see if there are any changes.
To take part in this study, you must be an adult over 18 years old and have been in the ICU for at least 24 hours. You should also be able to read and speak Danish. If you are unable to give consent yourself, a close family member can help with that. However, if you are very unstable and need immediate medical adjustments, you won't be able to join the study. This trial aims to provide insight into how live music might help patients feel better during a challenging time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults (\>18 years)
- • Admitted to one of the four participating ICU departments for a minimum of 24 hours
- • Able to read and speak Danish
- • For incapable patients, it is necessary to have a close relative (e.g., spouse or adult child), as these will provide proxy consent for study participation
- Exclusion Criteria:
- • Unstable patients with a need of change/adjustment of the ongoing treatment of e.g. drug infusions or ventilator settings during the music intervention, as this can possibly affect the HRV measurements.
About Aarhus University Hospital
Aarhus University Hospital is a leading research institution in Denmark, dedicated to advancing medical science and improving patient care through innovative clinical trials. As a key sponsor of clinical research, the hospital integrates cutting-edge technology and multidisciplinary expertise to conduct studies that address critical health challenges. With a commitment to ethical standards and patient safety, Aarhus University Hospital collaborates with a diverse network of academic and industry partners, ensuring that its research initiatives contribute to the global body of medical knowledge and enhance treatment options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus, Region Midtjylland, Denmark
Patients applied
Trial Officials
Linette Thorn, Master
Principal Investigator
Aarhus University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported